Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mouse Subcutaneous Immunotherapy in Mouse Sensitive Adults
NCT02532179Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Oct 2015
- Primary completion
- Oct 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Mouse allergenic extract in asthma, perennial allergic rhinitis (PAR), sponsored by National Institute of Allergy and Infectious Diseases. Started Oct 2015; status: completed.
02
Drugs
Mouse allergenic extract
03
Conditions
asthmaperennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT02532179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02532179.